G Parmiani
Overview
Explore the profile of G Parmiani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
306
Citations
3461
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Di Giacomo A, Ascierto P, Queirolo P, Pilla L, Ridolfi R, Santinami M, et al.
Ann Oncol
. 2014 Dec;
26(4):798-803.
PMID: 25538176
Background: In the NIBIT-M1 study, we reported a promising activity of ipilimumab combined with fotemustine in metastatic melanoma (MM) patients with or without brain metastases. To corroborate these initial findings,...
2.
Anichini A, Fossati G, Parmiani G
Immunol Today
. 2014 Oct;
8(12):385-9.
PMID: 25291274
A variety of cloning techniques are being applied to the analysis of phenotype, specificity and mechanism of action of cytolytic T cells on autologous tumor cells. Technical factors are influencing...
3.
4.
Parmiani G, Sensi M, Fossati G
Immunol Today
. 2014 Oct;
6(7):215-8.
PMID: 25290183
Experimental tumors may express cell surface antigens which cross-react with alloantigens of normal allogeneic tissues(1). These may be H-2 or non-H-2 histocompatibility antigens and differentiation antigens(1-3). Because of this cross-reactivity...
5.
Maio M, Danielli R, Chiarion-Sileni V, Pigozzo J, Parmiani G, Ridolfi R, et al.
Ann Oncol
. 2013 Sep;
24(11):2911-5.
PMID: 24067719
Background: Patients with advanced uveal melanoma have a poor prognosis and limited treatment options. Ipilimumab is approved for pre-treated adult patients with advanced melanoma. However, because previous clinical trials with...
6.
Parmiani G, Arienti F, Melani C, Belli F, Gallino G, Mazzocchi A
Methods Mol Med
. 2012 Feb;
61:203-22.
PMID: 22323260
The identification of genes involved in different biologic functions and in the pathogenesis of diseases has paved the way to the possibility of either interfering with the role of such...
7.
8.
Pilla L, Rivoltini L, Patuzzo R, Marrari A, Valdagni R, Parmiani G
Expert Opin Biol Ther
. 2009 Jul;
9(8):1043-55.
PMID: 19591629
Since the identification of tumor associated antigens (TAA) in different tumor histotypes, many vaccination strategies have been investigated, including peptide-based vaccines. Results from the first decade of clinical experimentation, though...
9.
Iero M, Valenti R, Huber V, Filipazzi P, Parmiani G, Fais S, et al.
Cell Death Differ
. 2007 Oct;
15(1):80-8.
PMID: 17932500
Tumour cells release vesicular structures, defined as microvesicles or exosomes, carrying a large array of proteins from their originating cell. The expression of antigenic molecules recognized by T cells has...
10.
Parmiani G, Castelli C, Pilla L, Santinami M, Colombo M, Rivoltini L
Ann Oncol
. 2006 Nov;
18(2):226-32.
PMID: 17116643
Granulocyte-macrophage colony-stimulating factor (GM-CSF) has been and is still widely used as an adjuvant in clinical trials of vaccination with autologous tumor cells, peptides and/or dendritic cells in a variety...